1 Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA.
2 Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK.
3 Center for Systems Biology, Massachusetts General Hospital, Boston, MA, 02114, USA.
4 Harvard Graduate School of Arts and Sciences, Cambridge, MA, 02138, USA.
5 Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA.
6 Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, 02115, USA.
7 Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
8 Oxford Centre for Translational Myeloma Research, Botnar Research Centre, University of Oxford, Oxford, OX3 7LD, UK.
9 Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 7LD, UK.
10 Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 7LD, UK.
11 Department of Chemistry & Chemical Biology, Harvard University, Cambridge, MA, 02138, USA.
12 Department of Bioengineering, Northeastern University, Boston, MA, 02115, USA.
13 Bristol Myers Squibb, Summit, NJ, 07901, USA.
14 Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.
15 Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA. Teru_Hideshima@dfci.harvard.edu.
16 Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA. Kenneth_Anderson@dfci.harvard.edu.
17 Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK. Udo.Oppermann@ndorms.ox.ac.uk.
18 Oxford Centre for Translational Myeloma Research, Botnar Research Centre, University of Oxford, Oxford, OX3 7LD, UK. Udo.Oppermann@ndorms.ox.ac.uk.